Clinical impact of early changes in guideline-directed medical therapy after mitral valve transcatheter edge-to-edge repair
European Journal of Heart Failure · 2026
DOI: 10.1093/ejhf/xuag005 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, 2026. Verfasst von Ayano Yoshida und 30 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osakasayama, Osaka 589-8511, Japan. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Registries, Stroke Volume, Cardiac Catheterization. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Edwards Life Sciences, Medtronic Japan, Boston Scientific.
Abstract (Originalsprache)
Background and Aims Mitral transcatheter edge-to-edge repair (M-TEER) is an established therapy for functional mitral regurgitation (FMR) and reduced left ventricular ejection fraction (LVEF). Although guideline-directed medical therapy (GDMT) is ideally optimized before M-TEER, this procedure may facilitate early post-procedural GDMT changes. However, the clinical impact of early in-hospital GDMT modifications remains unclear.
Methods
We analyzed 1,638 patients with FMR and LVEF <50% enrolled in a multicenter Japanese registry. The patients were stratified according to the number of GDMT classes prescribed at discharge (single [n=183]; double [n=505]; triple [n=630]; quadruple [n=320]). Changes from before M-TEER to discharge were categorized as increased (n=271), unchanged (n=1,219), or decreased (n=148). Associations between GDMT patterns and subsequent outcomes were evaluated. The primary endpoint was a composite of all-cause mortality and heart failure rehospitalization at one year.
Results
Primary endpoints were achieved in 357 patients (22%). Event rates decreased across groups (single, 32%; double, 24%; triple, 21%; quadruple, 14%; P<0.001). After adjusting for confounders, a greater number of GDMT classes at discharge independently predicted better prognosis. (hazard ratio [HR]: 0.83; 95% confidence interval [CI]: 0.73–0.95), whereas pre-M-TEER GDMT was not significant. Compared with decreased GDMT, an unchanged status was not associated with improved outcomes, while an increased status significantly improved prognosis (HR 0.62, 95% CI 0.39–0.99).
Conclusion
In patients with FMR and LVEF <50%, a higher number of GDMT classes at discharge and in-hospital uptitration of the GDMT class were associated with better outcomes, suggesting that early postprocedural GDMT optimization warrants further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osakasayama, Osaka 589-8511, Japan.
- Department of Cardiology, Toyohashi Heart Center, Toyohashi, Japan.
- Department of Cardiology, Gifu Heart Center, Gifu, Japan.
- Department of Cardiology, Nagoya Heart Center, Nagoya, Japan.
- Department of Cardiology, Sakakibara Heart Institute, Fuchu, Japan.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo, Japan.
ORCID-Profile: Ayano Yoshida, Masanori Yamamoto, Gaku Nakazawa, Tatsuya Miyoshi, Mike Saji, Masahiko Asami, Yusuke Enta, Masaki Izumo, Yusuke Watanabe, Hisao Otsuki, Toru Naganuma, Yohei Ohno, Daisuke Hachinohe, Kentaro Hayashida
Förderung
- Edwards Life Sciences
- Medtronic Japan
- Boston Scientific
- Abbott Medical Japan
- Daiichi-Sankyo Company
Zitieren
APA
Yoshida, A., Yamamoto, M., Nakazawa, G., Mizutani, K., Yamada, N., Soejima, N., Kawamura, T., Matsuzoe, H., Miyoshi, T., Saji, M., Kubo, S., Asami, M., Enta, Y., Shirai, S., Izumo, M., Mizuno, S., Watanabe, Y., Amaki, M., Kodama, K., …, & Hayashida, K. (2026). Clinical impact of early changes in guideline-directed medical therapy after mitral valve transcatheter edge-to-edge repair. European Journal of Heart Failure. https://doi.org/10.1093/ejhf/xuag005
Vancouver
Yoshida A, Yamamoto M, Nakazawa G, Mizutani K, Yamada N, Soejima N, et al. Clinical impact of early changes in guideline-directed medical therapy after mitral valve transcatheter edge-to-edge repair. European Journal of Heart Failure. 2026. doi:10.1093/ejhf/xuag005
BibTeX
@article{Yoshida2026,
author = {Yoshida, Ayano and Yamamoto, Masanori and Nakazawa, Gaku and Mizutani, Kazuki and Yamada, Nobuhiro and Soejima, Naoko and Kawamura, Takayuki and Matsuzoe, Hiroki and Miyoshi, Tatsuya and Saji, Mike and Kubo, Shunsuke and Asami, Masahiko and Enta, Yusuke and Shirai, Shinichi and Izumo, Masaki and Mizuno, Shingo and Watanabe, Yusuke and Amaki, Makoto and Kodama, Kazuhisa and Otsuki, Hisao and Naganuma, Toru and Bota, Hiroki and Ohno, Yohei and Yamawaki, Masahiro and Ueno, Hiroshi and Hachinohe, Daisuke and Izumi, Yuki and Shimura, Tetsuro and Sugiura, Atsushi and Otsuka, Toshiaki and Hayashida, Kentaro},
title = {Clinical impact of early changes in guideline-directed medical therapy after mitral valve transcatheter edge-to-edge repair},
journal = {European Journal of Heart Failure},
year = {2026},
doi = {10.1093/ejhf/xuag005}
}
EUVIMED